Hoosier Cancer Research Network
@hoosiercancer.bsky.social
Hoosier Cancer Research Network conducts innovative cancer research studies with more than 100 academic and community sites across the United States.
CEO Brian Stemme reflects on a year of progress and collaboration at HCRN. Read more: hoosiercancer.org/a-thank-you-...
A Thank You for Your Commitment to Advancing Cancer Research - Hoosier Cancer Research Network
As we reflect on the past year, I want to thank our investigators, sites, funders, and the entire Hoosier Cancer Research Network team for your continued commitment to investigator-initiated cancer re...
hoosiercancer.org
January 21, 2026 at 7:04 PM
CEO Brian Stemme reflects on a year of progress and collaboration at HCRN. Read more: hoosiercancer.org/a-thank-you-...
HCRN welcomes Anna Pavlick, DO, MBA (Weill Cornell), Michael C. Lowe, MD, MA (Emory Winship), and Arkadiusz Z. Dudek, MD, PhD (Mayo Clinic) as co-chairs of the Melanoma Clinical Trial Working Group.
👉 Read more: hoosiercancer.org/collaborativ...
#HCRN #Melanoma #CancerResearch
👉 Read more: hoosiercancer.org/collaborativ...
#HCRN #Melanoma #CancerResearch
September 2, 2025 at 1:26 PM
HCRN welcomes Anna Pavlick, DO, MBA (Weill Cornell), Michael C. Lowe, MD, MA (Emory Winship), and Arkadiusz Z. Dudek, MD, PhD (Mayo Clinic) as co-chairs of the Melanoma Clinical Trial Working Group.
👉 Read more: hoosiercancer.org/collaborativ...
#HCRN #Melanoma #CancerResearch
👉 Read more: hoosiercancer.org/collaborativ...
#HCRN #Melanoma #CancerResearch
HCRN welcomes Neelima Vidula, MD (Mass General Hospital) & Alison Conlin, MD, MPH (Providence Cancer Institute) as co-chairs of the Breast Cancer Clinical Trial Working Group, joining Carey Anders, MD (Duke Cancer Institute).
Read more: hoosiercancer.org/collaborativ...
Read more: hoosiercancer.org/collaborativ...
August 26, 2025 at 2:05 PM
HCRN welcomes Neelima Vidula, MD (Mass General Hospital) & Alison Conlin, MD, MPH (Providence Cancer Institute) as co-chairs of the Breast Cancer Clinical Trial Working Group, joining Carey Anders, MD (Duke Cancer Institute).
Read more: hoosiercancer.org/collaborativ...
Read more: hoosiercancer.org/collaborativ...
We surveyed more than 130 researchers across our network, and 72% of them said IITs have been pivotal to their careers.
HCRN’s latest report explores how investigator-initiated trials are driving #oncology research forward.
Read more and download the report: hoosiercancer.org/hcrns-report...
HCRN’s latest report explores how investigator-initiated trials are driving #oncology research forward.
Read more and download the report: hoosiercancer.org/hcrns-report...
HCRN’s Report Reveals Key Trends Shaping Investigator-Initiated Oncology Trials - Hoosier Cancer Research Network
Hoosier Cancer Research Network has released a new report, “Investigator-Initiated Oncology Trials: Trends, Challenges, and Opportunities,” that captures the experience and perspectives of more than 1...
hoosiercancer.org
July 14, 2025 at 1:27 PM
We surveyed more than 130 researchers across our network, and 72% of them said IITs have been pivotal to their careers.
HCRN’s latest report explores how investigator-initiated trials are driving #oncology research forward.
Read more and download the report: hoosiercancer.org/hcrns-report...
HCRN’s latest report explores how investigator-initiated trials are driving #oncology research forward.
Read more and download the report: hoosiercancer.org/hcrns-report...
HCRN’s new report shares insights from a survey of more than 130 researchers across our national network, revealing key trends, challenges, and the impact of IITs on cancer research.
Read more and download the report: hoosiercancer.org/hcrns-report...
Read more and download the report: hoosiercancer.org/hcrns-report...
July 2, 2025 at 6:46 PM
HCRN’s new report shares insights from a survey of more than 130 researchers across our national network, revealing key trends, challenges, and the impact of IITs on cancer research.
Read more and download the report: hoosiercancer.org/hcrns-report...
Read more and download the report: hoosiercancer.org/hcrns-report...
@medpagetoday.bsky.social published a writeup on HCRN-LUN18-335 (The "RAMOSE" study), which was led by Dr. Xiuning Le of the @mdanderson.bsky.social. This writeup was based on research published in @ascocancer.bsky.social's Journal of Clinical Oncology. Read more www.medpagetoday.com/reading-room...
Add-On Ramucirumab for EGFR-Mutant NSCLC
RAMOSE and RELAY trial results
www.medpagetoday.com
May 14, 2025 at 1:04 PM
@medpagetoday.bsky.social published a writeup on HCRN-LUN18-335 (The "RAMOSE" study), which was led by Dr. Xiuning Le of the @mdanderson.bsky.social. This writeup was based on research published in @ascocancer.bsky.social's Journal of Clinical Oncology. Read more www.medpagetoday.com/reading-room...
Congratulations to HCRN co-founder Dr. Rafat Ansari, who will receive an honorary Doctor of Science degree from @notredame.bsky.social at its 180th University Commencement Ceremony on May 18!
Read more: news.nd.edu/news/notre-d...
Read more: news.nd.edu/news/notre-d...
May 13, 2025 at 1:36 PM
Congratulations to HCRN co-founder Dr. Rafat Ansari, who will receive an honorary Doctor of Science degree from @notredame.bsky.social at its 180th University Commencement Ceremony on May 18!
Read more: news.nd.edu/news/notre-d...
Read more: news.nd.edu/news/notre-d...
We are excited to participate in the @ascocancer.bsky.social 2025 Annual Meeting in Chicago! Find us at booth #36117! Learn about our planned activities and featured abstracts at hoosiercancer.org/hcrns-presen... #ASCO2025
May 12, 2025 at 5:02 PM
We are excited to participate in the @ascocancer.bsky.social 2025 Annual Meeting in Chicago! Find us at booth #36117! Learn about our planned activities and featured abstracts at hoosiercancer.org/hcrns-presen... #ASCO2025
HCRN is looking for a passionate, dynamic communications and marketing coordinator who will help amplify our mission, reach new audiences, and elevate the impact of our research.
Learn more here: hoosiercancer.org/careers/#ope...
Learn more here: hoosiercancer.org/careers/#ope...
April 8, 2025 at 7:08 PM
HCRN is looking for a passionate, dynamic communications and marketing coordinator who will help amplify our mission, reach new audiences, and elevate the impact of our research.
Learn more here: hoosiercancer.org/careers/#ope...
Learn more here: hoosiercancer.org/careers/#ope...
Come out to the Indiana Statehouse for Breast Cancer Advocacy Day on Monday! Hoosier Cancer Research Network will be on hand to share how we support researchers working to improve the lives of cancer patients through clinical trials. fox59.com/morning-news...
March 30, 2025 at 5:28 PM
Come out to the Indiana Statehouse for Breast Cancer Advocacy Day on Monday! Hoosier Cancer Research Network will be on hand to share how we support researchers working to improve the lives of cancer patients through clinical trials. fox59.com/morning-news...
Study Highlight🧑⚕️🔬HCRN-GI23-643 is a randomized trial of regorafenib in combination with pembrolizumab or pembrolizumab monotherapy for patients with MSI-H colorectal cancer. Currently open to accrual at @adventhealth.bsky.social Orlando & @upmchillmancc.bsky.social. hoosiercancer.org/all-clinical...
March 26, 2025 at 3:08 PM
Study Highlight🧑⚕️🔬HCRN-GI23-643 is a randomized trial of regorafenib in combination with pembrolizumab or pembrolizumab monotherapy for patients with MSI-H colorectal cancer. Currently open to accrual at @adventhealth.bsky.social Orlando & @upmchillmancc.bsky.social. hoosiercancer.org/all-clinical...
HCRN launched an updated website with new features and a modernized design, developed in collaboration with THE PLAID AGENCY. Visit our new website and read more about it here: hoosiercancer.org/hcrn-launche...
March 21, 2025 at 5:01 PM
HCRN launched an updated website with new features and a modernized design, developed in collaboration with THE PLAID AGENCY. Visit our new website and read more about it here: hoosiercancer.org/hcrn-launche...
Hoosier Cancer Research Network CEO Brian Stemme talked last week with Inside Indiana Business about the impact of the @bigtencrc.bsky.social and how the HCRN team supports this vital work. www.youtube.com/watch?v=MuCc...
FULL SHOW: Indiana Farmers Brace for Tariffs, Big Ten's Fight Against Cancer, and Rural Education
YouTube video by Inside Indiana Business
www.youtube.com
March 17, 2025 at 2:36 PM
Hoosier Cancer Research Network CEO Brian Stemme talked last week with Inside Indiana Business about the impact of the @bigtencrc.bsky.social and how the HCRN team supports this vital work. www.youtube.com/watch?v=MuCc...
Researchers participating in the HCRN-GU16-260 study have published a correlative analysis in Cancer Discovery. Congratulations to all co-authors and study teams whose hard work led to this publication! Read more: hoosiercancer.org/correlative-...
February 27, 2025 at 4:55 PM
Researchers participating in the HCRN-GU16-260 study have published a correlative analysis in Cancer Discovery. Congratulations to all co-authors and study teams whose hard work led to this publication! Read more: hoosiercancer.org/correlative-...
A HCRN non-small cell lung cancer study (RAMOSE trial) was published and featured in the February 1, 2025 issue of the Journal of Clinical Oncology. Congratulations to all co-authors and study teams whose hard work led to this publication!
Read more: hoosiercancer.org/hcrn-non-sma...
Read more: hoosiercancer.org/hcrn-non-sma...
February 26, 2025 at 3:55 PM
A HCRN non-small cell lung cancer study (RAMOSE trial) was published and featured in the February 1, 2025 issue of the Journal of Clinical Oncology. Congratulations to all co-authors and study teams whose hard work led to this publication!
Read more: hoosiercancer.org/hcrn-non-sma...
Read more: hoosiercancer.org/hcrn-non-sma...
Congratulations to Dr. Deepak Kilari of @froedtert.bsky.social and all co-authors on presenting the ABATE study, HCRN-GU18-343! #GU25
February 14, 2025 at 9:03 PM
Congratulations to Dr. Deepak Kilari of @froedtert.bsky.social and all co-authors on presenting the ABATE study, HCRN-GU18-343! #GU25
Reposted by Hoosier Cancer Research Network
Exciting findings from the HCRN GU18-343 ABATE study: A phase 2 trial evaluating cabozantinib + atezolizumab as neoadjuvant treatment for muscle-invasive bladder cancer! 🚀🔬 Don’t miss the insights at @ascocancer.bsky.social #GU25
February 14, 2025 at 6:18 PM
Exciting findings from the HCRN GU18-343 ABATE study: A phase 2 trial evaluating cabozantinib + atezolizumab as neoadjuvant treatment for muscle-invasive bladder cancer! 🚀🔬 Don’t miss the insights at @ascocancer.bsky.social #GU25
HCRN is set to participate in @ascocancer.bsky.social GU 2025 in San Francisco from February 13-15, 2025, with HCRN-GU16-243 being presented as a Rapid Oral Abstract, and several other studies as poster presentations. Read more: hoosiercancer.org/five-hcrn-st...
Five HCRN studies presented at ASCO GU 2025, with HCRN-GU16-243 as a rapid oral abstract - Hoosier Cancer Research Network
Hoosier Cancer Research Network (HCRN) is set to participate in ASCO GU 2025 in San Francisco from February 13-15, 2025, with HCRN-GU16-243 being presented as […]
hoosiercancer.org
February 13, 2025 at 2:01 PM
HCRN is set to participate in @ascocancer.bsky.social GU 2025 in San Francisco from February 13-15, 2025, with HCRN-GU16-243 being presented as a Rapid Oral Abstract, and several other studies as poster presentations. Read more: hoosiercancer.org/five-hcrn-st...
HCRN-LUN21-497, titled, “Results from a phase II study of GT103 in combination with pembrolizumab in refractory, metastatic non-small cell lung cancer,” was presented at SITC 2024 by Jeffrey Clarke, MD, of Duke University.
Read more: hoosiercancer.org/hcrn-lun21-4...
Read more: hoosiercancer.org/hcrn-lun21-4...
HCRN-LUN21-497 presented at SITC 2024 - Hoosier Cancer Research Network
A Hoosier Cancer Research Network study, HCRN-LUN21-497, titled, “Results from a phase II study of GT103 in combination with pembrolizumab in refractory, metastatic non-small cell […]
hoosiercancer.org
January 28, 2025 at 3:12 PM
HCRN-LUN21-497, titled, “Results from a phase II study of GT103 in combination with pembrolizumab in refractory, metastatic non-small cell lung cancer,” was presented at SITC 2024 by Jeffrey Clarke, MD, of Duke University.
Read more: hoosiercancer.org/hcrn-lun21-4...
Read more: hoosiercancer.org/hcrn-lun21-4...
We are happy to announce our arrival on Bluesky! In addition to X, Facebook, and LinkedIn, you can now connect with us on here at @hoosiercancer.bsky.social. Follow us and join the growing conversation!
January 24, 2025 at 2:47 PM
We are happy to announce our arrival on Bluesky! In addition to X, Facebook, and LinkedIn, you can now connect with us on here at @hoosiercancer.bsky.social. Follow us and join the growing conversation!
HCRN-GI23-643 will be presented as a Trials in Progress poster at the @ascocancer.bsky.social Gastrointestinal Cancers Symposium 2025 in San Francisco. This study is led by Ibrahim Sahin, MD, of UPMC Hillman Cancer Center.
Read more: hoosiercancer.org/hcrn-gi23-64...
Read more: hoosiercancer.org/hcrn-gi23-64...
January 22, 2025 at 8:40 PM
HCRN-GI23-643 will be presented as a Trials in Progress poster at the @ascocancer.bsky.social Gastrointestinal Cancers Symposium 2025 in San Francisco. This study is led by Ibrahim Sahin, MD, of UPMC Hillman Cancer Center.
Read more: hoosiercancer.org/hcrn-gi23-64...
Read more: hoosiercancer.org/hcrn-gi23-64...
A correlative study related to HCRN-GU16-243 was presented at #SUO2024 by Noah Hahn, MD, of Sidney Kimmel Comprehensive Cancer Center.
Congratulations to Dr. Hahn and co-authors!
Read more: hoosiercancer.org/hcrn-gu16-24...
Congratulations to Dr. Hahn and co-authors!
Read more: hoosiercancer.org/hcrn-gu16-24...
HCRN-GU16-243 presented at SUO 2024 - Hoosier Cancer Research Network
A correlative study related to the Hoosier Cancer Research Network (HCRN) clinical trial, HCRN-GU16-243, titled, “A Phase 1 Trial of Durvalumab in Combination with Bacillus […]
hoosiercancer.org
January 15, 2025 at 7:37 PM
A correlative study related to HCRN-GU16-243 was presented at #SUO2024 by Noah Hahn, MD, of Sidney Kimmel Comprehensive Cancer Center.
Congratulations to Dr. Hahn and co-authors!
Read more: hoosiercancer.org/hcrn-gu16-24...
Congratulations to Dr. Hahn and co-authors!
Read more: hoosiercancer.org/hcrn-gu16-24...
Congrats to Rana Mckay of UC San Diego Health Moores Cancer Center on being elected to the @ascocancer.bsky.social Nominating Committee! She serves as a co-chair of the our GU Clinical Trial Working Group & is a sponsor-investigator of multiple HCRN studies.
connection.asco.org/do/dr-elizab...
connection.asco.org/do/dr-elizab...
January 15, 2025 at 4:45 PM
Congrats to Rana Mckay of UC San Diego Health Moores Cancer Center on being elected to the @ascocancer.bsky.social Nominating Committee! She serves as a co-chair of the our GU Clinical Trial Working Group & is a sponsor-investigator of multiple HCRN studies.
connection.asco.org/do/dr-elizab...
connection.asco.org/do/dr-elizab...